• Info
  • Insider Ownership

Insider Trading & Ownership of Dean J. Mitchell

Location
New York, NY
Summary
The estimated net worth of Dean J. Mitchell is at least $2.49M dollars as of September 25, 2025. Dean J. Mitchell is the Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $889K. Dean J. Mitchell is the Director of PRECIGEN, INC. and owns shares of PRECIGEN, INC. (PGEN) stock worth about $845K. Dean J. Mitchell is the Director of Praxis Precision Medicines, Inc. and owns shares of Praxis Precision Medicines, Inc. (PRAX) stock worth about $760K.
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Dean J. Mitchell files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Dean J. Mitchell

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TBPH Theravance Biopharma, Inc. Director $889K May 19, 2025
PGEN PRECIGEN, INC. Director $845K Mar 14, 2024
PRAX Praxis Precision Medicines, Inc. Director $760K Sep 24, 2025
IMGN ImmunoGen, Inc. Director $0 Feb 12, 2024
KNTE Kinnate Biopharma Inc. Director Apr 3, 2024

Insider Transactions Reported by Dean J. Mitchell:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.